Infectious disease correlation with Non-Communicable Diseases

The recent research has highlighted a merging of epidemics involving both infectious and non-communicable diseases, deviating from the traditional epidemiological transition where societies typically transition from primarily infectious diseases to predominantly non-communicable diseases over time.

On a global scale, the collective proportion of measurable Non-Communicable Disease (NCD) burden attributed to infectious causes (~8.4%) surpassed the proportions linked to certain prevalent risk factors like-

  • high LDL cholesterol (6.1%),

  • air pollution (6.7%), and

  • alcohol use (4.5%).  

Determinants of NCD outcome following infection

Host

Host factors like-

  • Age, gender, genetics, immune response, and nutritional status collectively influence infection susceptibility and disease outcomes.

  • Genetic variations in genes related to immune regulation, such as IL-10, TGF β, TNF, and other cytokines, contribute to NCDs linked to infections, including asthma and allergies.

Infectious agents

Certain infection strains induce NCDs through:

  • Release of cytotoxic products.

  • Triggering an exaggerated and dysregulated immune response.

  • Resulting in tissue damage.

Environment

Infections extend the risk of non-communicable diseases (NCDs) beyond environmental factors, acting as triggers, co-factors, or primary contributors to NCD etiology.

  • The collaboration of infections with environmental factors is evident in chronic obstructive pulmonary disease (COPD).

  • Heightened hygiene reduces early childhood infections, favoring an unbalanced stimulation of the TH2 cytokine arm over the TH1 cytokine arm.

  • This imbalance increases susceptibility to asthma and allergies in hygienic children.

NCD mechanism involves

  • Description text goes here
  • Item description

Infectious conditions contribute significantly to NCD burden, varying regionally.

To effectively reduce NCD burden, especially in low-income and middle-income countries:

o   Strengthen availability, coverage, and quality of cost-effective interventions for key infectious conditions.

o   Universal health coverage efforts should address infectious risks leading to NCDs.

o   Prioritize populations with high rates of infectious conditions to minimize regional disparities in NCD burden.

Estimates of this burden are expected to rise with expanding evidence for quantification.